EXPANDED TABLE OF CONTENTS
VOLUME 7, NUMBER 8 AUGUST 2004
|
| TREATMENT HIGHLIGHTS |
| APPEARANCE VERSUS HEALTH AS MOTIVATION FOR DIETING |
| The dieting behavior of women who diet for appearance reasons is found to differ from that of women who diet out of concern for health. |
| PREDICTORS OF SUICIDAL BEHAVIOR |
| Among patients with a mood disorder, future suicidal behavior is found to be predicted by pessimism and aggression/impulsivity, as well as by well-established predictors, such as history of suicide attempt. |
| TRACKING THE DATA |
| TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER |
| The first followup phase of the Multimodal Treatment Study of ADHD examines maintenance of treatment effectiveness and the impact of medication on height suppression. |
| OF NOTE |
| Smoking On-screen by Movie Stars and its Association With the Onset of Smoking by Adolescents |
| ETCETERA |
| Health Risks and Health Benefits of Moderate Alcohol Consumption |
| PSYCHOTROPIC DRUG COMPARISON STUDY |
| BUPRENORPHINE VS METHADONE IN THE TREATMENT OF OPIOID DEPENDENCE |
| Buprenorphine and methadone were both found to be effective in the maintenance treatment of opioid dependence, with some findings suggesting advantages in the use of buprenorphine. |
| FDA NEWS AND REVIEW |
| Approval (new drug) of Campral (acamprosate calcium) Delayed-Release Tablets. Indication: maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation.
|
| Approval (new drug) of Cymbalta (duloxetine hydrochloride) Capsules. Indication: treatment of major depressive disorder.
|
| ASSESSMENT |
| Eating Disorder Diagnostic Scale (EDDS) |
| RESOURCES |
| Each issue presents descriptions of clinical resources (eg, professional materials, patient handouts) and information on how to receive those materials. |